Does GLP-1 Show Up in Blood Work?

Not the drug itself. A routine panel or a workplace drug screen does not test for semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound). What a panel can show is what the medication does: lower HbA1c and glucose, shifted lipids, and sometimes raised lipase or creatinine.

Medically reviewed · Guideline-anchored · Updated Oct 19, 2026

Reviewed by Dr. Prahlad Rai Gupta, MBBS, MD · Thresholds anchored to FDA prescribing information for semaglutide and tirzepatide · Evidence & Methodology

Routine panels and drug screens covered Which markers a GLP-1 moves What to test, not how to dose

Starting or already on a GLP-1?

The before-and-after guide covers which markers to baseline and when each one is worth retesting.

See GLP-1 before-and-after blood work

The medication is not on the panel. Its effects are.

A blood panel reports a fixed list of your own markers. Nothing on a CBC, metabolic panel, lipid panel or HbA1c measures a GLP-1 medication.

Measuring semaglutide or tirzepatide in blood takes a drug-specific assay of the kind used in clinical trials. It is not something a GP orders with routine bloods, and a lab will not run it unless asked for that test by name.

Drug screens are built the same way. Standard employment and DOT panels test for named controlled substances such as opioids, amphetamines, cocaine and cannabis. GLP-1 receptor agonists are not controlled substances and are not on those panels.

How long the drug stays in your blood is a separate question from whether a test looks for it. The Ozempic label puts semaglutide's half-life at about one week and says it stays in circulation for about five weeks after the last dose. Tirzepatide's half-life is about five days. Neither changes what a routine panel reports.

What a panel can show is the effect, and those changes are worth reading on purpose rather than by accident. The full baseline-and-retest plan is on the GLP-1 before-and-after blood work guide.

What a GLP-1 can change on routine blood work

Four groups. None of these proves someone is taking a GLP-1; each has other causes. Read them against a result from before you started.

Cluster 1 of 4

Blood sugar

Lowering blood sugar is what these medications are approved to do in type 2 diabetes, so this is where the change is most expected.

Core Usually in a standard panel Ask Request specifically

Core

HbA1c

A 3-month average, so it lags. A result taken in the first 10–12 weeks still mostly reflects your pre-treatment months. See the HbA1c guide.

Core

Fasting Glucose

Can move within weeks. Low readings are uncommon on a GLP-1 alone; the risk rises when it is combined with insulin or a sulfonylurea, which the label flags.

Cluster 2 of 4

Pancreas

The FDA labels report increases in pancreatic enzymes in trial participants, and list acute pancreatitis as a warning.

Core Usually in a standard panel Ask Request specifically

Ask

Lipase & Amylase

Not on a standard panel. A raised lipase without symptoms is a known finding on these drugs; severe, persistent abdominal pain is the warning sign the label tells you to act on, whatever the number says.

Cluster 3 of 4

Kidneys and hydration

Nausea, vomiting and diarrhoea are the common side effects, and the labels warn that the fluid loss can cause acute kidney injury.

Core Usually in a standard panel Ask Request specifically

Core

Creatinine & eGFR

On a standard metabolic panel. A rise after a stretch of vomiting or poor fluid intake is a dehydration pattern worth reporting. See dehydration and blood test results.

Core

BUN

Often rises with creatinine when you are dehydrated. Read the two together through the BUN/creatinine ratio.

Cluster 4 of 4

Lipids and liver

Weight loss and better blood sugar control both tend to show up here, more slowly than glucose.

Core Usually in a standard panel Ask Request specifically

Core

Triglycerides

Usually the lipid that moves first with reduced food intake. The standard flag is above 150 mg/dL.

Core

ALT

If it was raised from fatty liver before you started, a fall over months is the expected direction as liver fat drops with weight loss.

Frequently asked questions

Does semaglutide show up in routine blood work?

No. Routine panels (CBC, metabolic panel, lipid panel, HbA1c) measure your own markers, not medications. Semaglutide can only be measured with a drug-specific assay that is not part of routine testing. The panel can still show its effects, most often a lower HbA1c and fasting glucose.

Will Ozempic or Mounjaro show up on a drug test?

Standard drug screens, including employment and DOT panels, test for named controlled substances such as opioids, amphetamines, cocaine and cannabis. Semaglutide and tirzepatide are not controlled substances and are not on those panels.

Can a doctor tell I am on a GLP-1 from my blood test?

Not from the blood test alone. A falling HbA1c, lower triglycerides or a raised lipase fit GLP-1 use but have other explanations too. Tell whoever orders your bloods that you take one, so the results are read against the right baseline.

How long does semaglutide stay in your blood?

The Ozempic label gives semaglutide a half-life of about one week and says it stays in circulation for about five weeks after the last dose. Tirzepatide's half-life is about five days. Routine panels do not look for either.

Is there a GLP-1 blood test?

Some labs sell a "GLP-1" test, which measures the hormone your gut makes, not the medication. It is used in research and is not part of routine monitoring on semaglutide or tirzepatide. Monitoring on these drugs uses the standard markers on this page.

References & Guidelines

Keep reading: GLP-1 before-and-after blood work · HbA1c blood test explained · BUN/creatinine ratio

If your results changed after starting

A changed HbA1c, lipid or kidney result is easier to read next to the one from before you started.

Upload to FixFirst

Get your top 3 priorities ranked in 45 seconds

Upload your report and FixFirst checks all 254 markers against standard clinical thresholds, adjusted for your sex and context.

Upload My Report →

More therapy-monitoring pages

See the full Peptides & Hormones section

GLP-1, TRT and sermorelin before-and-after blood work.

Browse Peptides & Hormones

Free · No account · 45 seconds

Read your results against the same clinical thresholds before and after.

Upload your blood report and get a ranked read on every marker, adjusted for your context.

Analyze My Blood Test →

Any lab PDF or phone photo · Processed in memory, never stored

FixFirst is free, with no ads and no account. If this guide helped, a coffee keeps it that way.